Establishment Labs Holdings Inc. (ESTA) Stock Forecast

NASDAQ: ESTAAnalyst ratings, price target and estimates.

ESTA analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.80 / 5 from 10 analysts
Price target
$100.70
average of analyst targets
Upside to target
+70.2%
from the latest close
Next earnings
November 4, 2026
EPS estimate $-0.32
52-week range
$47.80 – $95.65

ESTA analyst ratings

10 analysts
Strong buy
880%
Buy
220%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ESTA price target

Price $59.18Target $100.70
52-week low $47.8052-week high $95.65

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ESTA earnings per share estimates

Establishment Labs Holdings Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.23−$0.24−$0.22−$0.38+39.5%2
Current fiscal year (2026)−$1.10−$1.12−$1.08−$1.74+36.9%2
Next fiscal year (2027)$0.06−$0.01$0.13−$1.10+105.5%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ESTA revenue estimates

Establishment Labs Holdings Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$66.8M$65.4M$68.5M+24.2%10
Current fiscal year (2026)$270.2M$269.1M$271.0M+28.0%10
Next fiscal year (2027)$339.1M$337.5M$342.4M+25.5%10

ESTA EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ESTA revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ESTA EPS estimate revisions

Establishment Labs Holdings Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.23−$0.23−$0.23−$0.23−$0.23−2.1%1 up · 1 down
Current fiscal year (2026)−$1.01−$1.10−$1.10−$1.10−$1.10+8.4%0 up · 2 down
Next fiscal year (2027)$0.07$0.06$0.06$0.06$0.06−20.0%0 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ESTA earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ESTA beat in 6 of 12.

What analysts expect from ESTA

10 analysts cover Establishment Labs; their consensus rating is strong buy (4.80 on a 1–5 scale, where 5 is a strong buy). The average price target is $100.70, 70.2% above the latest close of $59.18. Analysts expect earnings of −$1.10 per share for 2026, +36.9% from a year earlier. For 2027 the average estimate is $0.06 per share on revenue of $339.1 million. Establishment Labs beat the EPS estimate in 6 of the last 12 quarters.

Related: ESTA income statement, ESTA key metrics, ESTA chart. See the ESTA stock overview for the latest quote and news.

ESTA forecast FAQ

What is Establishment Labs's price target?

The average analyst price target for Establishment Labs is $100.70, 70.2% above the latest close of $59.18.

Is Establishment Labs a buy, hold or sell?

Of 10 analysts covering Establishment Labs, 8 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Establishment Labs's EPS forecast?

Analysts forecast −$1.10 per share for 2026 (range −$1.12 to −$1.08); for 2027 the estimate is $0.06.

What is Establishment Labs's revenue forecast?

The average revenue estimate for 2026 is $270.2 million, growth of 28.0%; for 2027 it is $339.1 million.

When does Establishment Labs report earnings?

Establishment Labs is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $-0.32.

Does Establishment Labs usually beat earnings estimates?

Establishment Labs reported EPS at or above the analyst estimate in 6 of the last 12 quarters.

Medical Devices: forecast